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Loss of pluripotency is a gradual event whose initi-
ating factors are largely unknown. Here we report
the earliest metabolic changes induced during the
first hours of differentiation. High-resolution NMR
identified 44 metabolites and a distinct metabolic
transition occurring during early differentiation. Meta-
bolic and transcriptional analyses showed that plurip-
otent cells produced acetyl-CoA through glycolysis
and rapidly lost this function during differentiation.
Importantly,modulation of glycolysis blocked histone
deacetylation and differentiation in human andmouse
embryonic stem cells. Acetate, a precursor of acetyl-
CoA, delayed differentiation and blocked early his-
tone deacetylation in a dose-dependent manner.
Inhibitors upstream of acetyl-CoA caused differentia-
tion of pluripotent cells, while those downstream de-
layed differentiation. Our results show a metabolic
switch causing a loss of histone acetylation and
pluripotent state during the first hours of differentia-
tion. Our data highlight the important role metabolism
plays in pluripotency and suggest that a glycolytic
switch controlling histone acetylation can release
stem cells from pluripotency.
INTRODUCTION
Pluripotent stem cells (PSCs) are defined by their self-renewal
and the ability to differentiate into all adult cell types (Blair392 Cell Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc.et al., 2011). Supported by growth factors such as bFGF, the
pluripotent state is defined by a handful of transcription factors,
including OCT4, SOX2, and NANOG. The loss of the pluripotent
state is a relatively slow process, leading over days to the
gradual acquisition of a different transcriptional state. Impor-
tantly, the earliest events initiating this loss of pluripotency during
the first steps of differentiation are largely unknown.
Metabolic processes are leading candidates for regulating this
transition, as chemical fluxes change within minutes and can
affect both transcriptional and epigenetic mechanisms. In fact,
the metabolic profile of PSCs was found to be different from
that of their terminally differentiated somatic counterparts (Cezar
et al., 2007; Folmes et al., 2011; Meissen et al., 2012; Panopou-
los et al., 2012; Shyh-Chang et al., 2013; Yanes et al., 2010). PSC
metabolism showed the Warburg effect, a shift from oxidative
phosphorylation to aerobic glycolysis characteristic of cancer
cells (Folmes et al., 2011; Panopoulos et al., 2012; Zhu et al.,
2010). This increase in glycolysis generates ATP at a faster rate
than oxidative phosphorylation, while producing less reactive
oxygen species (ROS), an important feature for rapidly prolifer-
ating cells. Glycolysis also shunts into the pentose phosphate
pathway, producing much-needed nucleotides for proliferation
(Vander Heiden et al., 2009).
In fact, glycolysis has recently been shown to increase reprog-
raming efficiency of human andmouse fibroblasts (Folmes et al.,
2011; Zhu et al., 2010). PS48, a PDK1 activator that blocks the
entrance of pyruvate to the mitochondria, enhanced reprogram-
ming efficiency (Zhu et al., 2010), while DCA, a PDK1 inhibitor,
significantly reduced reprogramming (Folmes et al., 2011). Inter-
estingly, both acetate and acetyl-CoA (Ac-CoA) were found to be
elevated in metabolic profiles of PSCs at the end of differentia-
tion process. However, the dynamics of this metabolic change
are unclear. Importantly, although Ac-CoA is a cornerstone of
both carbohydrate and lipid metabolism, its origin and role in
regulating stem cell pluripotency are largely unknown.
Recently, Shyh-Chang and colleagues demonstrated that
threonine metabolism led to accumulation of Ac-CoA in mouse
embryonic stem cells (mESCs), fueling synthesis of S-adenosyl-
methionine (SAM) for histone methylation (Shyh-Chang et al.,
2013). In addition, earlier work showed the role of ATP-citrate
lyse (ACLY) in producing Ac-CoA for histone acetylation of so-
matic cells (Wellen et al., 2009).
In this work, we sought to identify the earliest metabolic
changes induced during the first hours of spontaneous differen-
tiation. High-resolution nuclear magnetic resonance (NMR) ana-
lyses identified 44 metabolites, showing a gradual transition in
metabolism over the first 48 hr of spontaneous differentiation.
Surprisingly, glycolysis was driven toward production of Ac-
CoA and acetate in PSCs, in addition to lactate. Moreover, ace-
tate stimulation blocked early histone deacetylation, delaying
loss of pluripotency and differentiation. We show that glycolytic
inhibitors upstream of acetate caused the differentiation of
PSCs, while those downstream of acetate delayed the exit from
pluripotency. Our data suggest that a rapid loss of glycolysis in
early differentiation downregulates Ac-CoA and acetate produc-
tion, causing loss of histone acetylation and associated loss of
pluripotency. It highlights a critical role for metabolism in the
maintenance of chromatin at the pluripotent state, suggesting
that a glycolytic switch triggers the loss of pluripotency during
the earliest steps of differentiation.
RESULTS
The Metabolic Profile of hPSCs Changes during Early
Differentiation
To study the earliest metabolic changes during the first steps of
differentiation, we cultured I3 and I4 human embryonic stem cells
(hESCs) in suspension (Figure 1A) (Amit et al., 2011) and removed
bFGF from the medium for unbiased spontaneous differentia-
tion. No significant changes were noted in the expression of the
pluripotency markers OCT4, NANOG, or REX1 during the first
48 hr of differentiation (Figure 1B), but changes in early-specifica-
tion genes PAX6 and Brachyury indicated early differentiation
(Figure 1C). Despite the mild changes in gene expression, partial
least-squares discriminant analysis (PLS-DA) of NMR spectral
bins demonstrated significant changes in the metabolic profile
of hESCmedia (Figure 1D;FiguresS1AandS1B;p<0.001byper-
mutation test) and extracts (Figure 1E; p = 0.019 by permutation
test) as early as 24 hr into differentiation. This metabolic shift
was further corroborated by hierarchical clustering analysis (Fig-
ure 1F). Altogether, 44 metabolites were identified (Figure S1C),
constructing the firstmetabolic profile of PSCsduring early differ-
entiation, aswell as the first comprehensivedataset of themetab-
olome of hESC cultivated in suspension as far as we know.
Loading plots of extracellular and intracellular metabolites (Fig-
ure 1G) showed that lactate, acetate, and phosphocholine levels
discriminated pluripotent from early-differentiated cells. The
abundance of lactate and acetate was higher in I4 and I3 hESC
samples and dropped during early differentiation (Figure 1H). To
focus our analysis on metabolic pathways that affect differentia-
tion, we exposed differentiating hESCs to the discriminatory me-
tabolites identified above. Acetate addition significantly delayedCethe loss of pluripotency marker SSEA4 (Figure 1I), suggesting
that this metabolite may be involved in cell exit of pluripotency.
Rapid Loss of Glycolysis-Produced Ac-CoA during Early
Differentiation
Acetate is produced from Ac-CoA, a common building block of
lipids and an endpoint of glycolysis. Indeed, we show a 2-fold
higher concentration of Ac-CoA in pluripotent cells compared
to early-differentiating cells (p % 0.01; Figure 2A). Interestingly,
pluripotent cells show little uptake of fatty acids or cholesterol
(Figures 2B–2D), suggesting that Ac-CoA production is primarily
driven by an increased rate of glycolysis that is 2–3 orders of
magnitude higher (Figures 2E and 2F). Indeed, metabolic flux
tracing shows a 3-fold higher 13C Ac-CoA production
in pluripotent cells compared to early differentiation following
D-Glucose-13C6 feeding (Figure 2G).
Quantitative gene expression analysis shows 2-, 5-, and 4-fold
lower expression of pyruvate dehydrogenase (PDH) complex
genes, ACLY, and acetyl-coenzyme A synthetase (ACCS2),
respectively, after 48 hr of spontaneous differentiation (Fig-
ure 2H). No significant change was noted in the expression of
CPT1A, an essential step in the b-oxidation of long-chain fatty
acids. Importantly, while stimulation of differentiating cells with
acetate increased Ac-CoA levels (p % 0.05), it did not affect
glycolysis (Figures 2E and 2F) or the expression ofACSS2, hence
meeting the cellular requirements for Ac-CoA. Proteomic anal-
ysis confirmed these findings, showing downregulation of
ACLY and ACSS2, but little change in PDHA1 and PDHB (Fig-
ure S2A). Proteome analysis also suggested a downregulation
of the monocarboxylate transporter SLC16A1, carrying short-
chain fatty acids with one carboxylate group. Altogether, these
data demonstrate that pluripotent cells direct glycolysis toward
the production of Ac-CoA in addition to lactate, in contrast to
the classic portrayal of the Warburg effect (Figure 2I).
Acetate Stimulation Delays Early Differentiation
of Human and Mouse ESCs
Acetate was previously shown to accumulate during reprogram-
ming of mouse induced pluripotent stem cells (iPSCs) (Folmes
et al., 2011), but its modulation failed to enhance reprogramming
efficiency. To characterize the effect of acetate on differentiation,
we tested the expression of the pluripotency markers Tra-1-60
and Tra-1-81 in I3 hESCs following 4 days of differentiation in sus-
pensionand foundasignificantdelay in thedownregulationofboth
pluripotency markers (Figures 3A and 3B). To validate this effect
across different cell lines, platforms, and species, we supple-
mented the media of H1 OCT4-GFP and mouse R1 OCT4-GFP
cellswithacetate.AcetateblockedOCT4 lossafter 4daysof spon-
taneous differentiation (Figures 3C and 3D) as well as the change
in colony morphology in R1 cells (Figure 3E). Cell number was
similar for all conditions, suggesting acetate treatment had no sig-
nificant effect on proliferation (Figure 3F). We next asked whether
acetate could also block directed differentiation. H1 hESCs were
induced toward endoderm using activin-A and Wnt3A, resulting
in 15% SOX17-positive cells after 24 hr (Figure 3G). The addition
of acetate blocked endodermal induction, with fewer than than
2.5% of the cells being positive for SOX17 (p < 0.001).
To study the dynamics of the effect of acetate on pluripotency,
we introduced acetate to hESC medium either 24 or 48 hr afterll Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc. 393
Figure 1. Metabolic Signatures of Early Differentiation
(A) Phase image of hESCs expanded and differentiated in high-density suspension culture. Bar, 100 mm.
(B) qRT-PCR analysis shows no significant changes in the expression of the pluripotency markers NANOG, OCT4, and REX1 during the first 48 hr of differen-
tiation.
(C) Early-differentiation markers PAX6 and Brachyury show minor but significant increase in expression over the same time period.
(D–F) High-resolution NMR unveils significant changes in extracellular metabolites during the first 24 hr of spontaneous differentiation, as determined by
multivariate tests of NMR spectra bins. (D) Partial least-squares discriminant analysis (PLS-DA) of 1H-NMR spectral bins of extracellular metabolites shows
significant changes after 24 hr of differentiation (p < 0.001; n = 10–12) and a clear gradient of metabolic change over the first 72 hr. (E) PLS-DA of intracellular
metabolites shows significant differences as well (p% 0.05; n = 4–6). (F) Hierarchical clustering separates NMR spectra bins of cell extracts at 0 and 48 hr.
(legend continued on next page)
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Figure 2. Rapid Loss of Glycolysis Produced Ac-CoA during Differentiation
(A–F) Targeted metabolomics corroborated significant changes in energy metabolism in H1 cells already at 24 hr of spontaneous differentiation. (A) Ac-CoA
production was significantly higher in mTeSR than in SpDiff medium. Upon addition of acetate (10 mM) to SpDiff medium, Ac-CoA levels were increased to the
levels found in mTeSR. (B and C) Fatty acid consumption and the production of ketone bodies by hESCs is minor, but upregulated in early-differentiating cells. (D)
Cholesterol is released from H1 cells in mTeSR medium and consumed in SpDiff medium with or without acetate. (E and F) Higher consumption of glucose and
production of lactate by hESCs, as expected in aerobic glycolysis.
(G) 13C Ac-CoA levels were significantly decreased in early-differentiating hESCs following incubation with 13C glucose.
(H) The expression of ACSS2, PDK2, PDHB, and ACLY, responsible for the formation of Ac-CoA, is significantly decreased during early spontaneous differ-
entiation (SpDiff). UCP2 levels showed only mild, although significant, change, and the expression of PDHA1, CPT1A, and SLC16A1 showed no significant
change.
(I) Glycolytic flux decreases upon early differentiation, redirecting from the formation of lactate and Ac-CoA to oxidative phosphorylation.
Error bars represent standard deviation. *p% 0.05; **p% 0.01; ***p% 0.001.induction of differentiation. Figure 3H shows that in both cases
acetate could still block the loss of OCT4 expression and even
rescue the pluripotent phenotype. We then added acetate to
hESCs cultivated with bFGF, without feeder cells. Acetate de-
layed the spontaneous loss of OCT4 in H1 cells after 5 days of
culture (Figure 3I), suggesting that acetate could complement
bFGF in maintaining pluripotency. This effect was still efficient
even after eight passages (Figures S3A and S3B). Finally, we
tested the effect of different concentrations of acetate on plurip-(G) PLS-DA loadings reveal lactate was an influential metabolite in the separation
were the discriminating metabolites in cell extract analysis (bottom).
(H) NMR peaks of secreted lactate (0 versus 48 hr) and intracellular acetate sho
ferentiated (red) hESCs.
(I) FACS analysis of SSEA4 in I4 hESCs cultured in SM10Fmedium compared to c
lactate, acetate, or choline (10mMeach). Acetate supplementation significantly d
0.05; **p% 0.01.
Ceotency. Acetate significantly and dose-dependently inhibited
loss of Tra1-81+/OCT4+ pluripotent cells in this model (Figures
3J and 3K).While the addition of 1mMof acetate exerted a highly
significant increase in the percentage of pluripotent cells, addi-
tion of citrate showed no effect (Figure S2C).
Acetate Increases Histone Acetylation in ESCs
Histone acetylation plays a critical role in the maintenance of
PSC open chromatin structure (Hezroni et al., 2011; Melcerof extracellular metabolites (top), while lactate, acetate, and phosphocholine
wing decrease of both at early-differentiating (blue) when compared to undif-
ells cultured in spontaneous differentiation medium (SpDiff) supplemented with
elayed loss of SSEA4 expression. Error bars represent standard deviation. *p%
ll Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc. 395
Figure 3. Acetate Delays Early Differentiation
(A and B) FACS analyses of I3 hESCs differentiated in suspension for 4 days. Spontaneous differentiation (SpDiff) led to a significant loss of the pluripotency
markers Tra-1-60 and Tra-1-81 compared to cells cultured in SM10F medium, while the addition of 10 mM acetate blocked this change.
(C and D) FACS analyses of H1 hESCs and R1 mESCs expressing OCT4-GFP show that 10 mM acetate significantly inhibited loss of OCT4 expression after
4 days of spontaneous differentiation.
(E) Phase images of R1mESCs show a rapid loss of pluripotent morphology during spontaneous differentiation (SpDiff), an effect that is negated by the addition of
10 mM acetate. mESCs cultured with LIF serve as negative control.
(F) Cell numbers were not affected by the addition of acetate to I3 cell media, similar to all tested lines.
(G) Immunofluorescence analysis shows acetate significantly delayed (p < 0.001) Sox17 expression following 48 hr of endoderm induction (Activin +Wnt3A) in H1
hESCs grown on Matrigel. H1 cells cultured in mTeSR provide a negative control.
(H) FACS analysis of H1 hESCs expressingOCT4-GFP shows that delayed addition of acetate, 24 and 48 hr post-differentiation, can similarly block loss of OCT4
expression.
(I) FACS analysis of H1 hESCs expressingOCT4-GFPmaintained for 5 days with bFGF and acetate shows higher OCT4 expression than those cultured on bFGF
alone. Naive cells grown in mTeSR provide negative controls for (C), (D), (H), and (I).
(J and K) FACS analyses of H1 hESCs expressing OCT4-GFP and stained with Tra-1-81. Left vertical axis and red bars represent the percentage of cells, which
are positive for both pluripotency markers. Right vertical axis and blue bars represent the percentage of cells, which are negative for both pluripotency markers.
The retention of the expression of OCT4 and Tra-1-81 by acetate is dose-dependent. In all histograms, unlabeled cells and isotype controls are represented in
gray. Error bars represent standard deviation. *p% 0.05; **p% 0.01; ***p% 0.001.et al., 2012; Ware et al., 2009). Ac-CoA is a substrate of acety-
lation, suggesting that acetate level might affect the histone
acetylation state of hESCs. To test this hypothesis, we stained
hESC colonies after 24 hr of spontaneous differentiation against
H3K9/K27ac, a well-known pan-acetylation marker, and H3K27
methylation. Differentiating cells lost H3K9/K27 acetylation at396 Cell Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc.the edges of the colony, while pluripotent cells did not (Figures
4A and 4B). The addition of acetate blocked the H3K9/K27
acetylation loss. H3K27 methylation was unaffected in all condi-
tions. We repeated the staining of hESCs after 24 hr of sponta-
neous differentiation with H3 and H4 pan-acetylation anti-
bodies, with similar results (Figures 4C and 4D). The addition
Figure 4. Acetate Induces Histone Pan-Acetylation
(A and B) Immunofluorescence staining of H3K9/K27 acetylation (green) and H3K27me3 methylation (red) during early differentiation. (A) Spontaneous differ-
entiation (SpDiff) causes loss of K9/K27ac acetylation in the circumference of the colony at 24 hr. Addition of 10mMacetate blocks this loss of histone acetylation.
Untreated colonies in mTeSR serve as negative control. H3K27me3 methylation was not affected in all cases. (B) Kinetics of K9/K27 acetylation normalized to
K27me3 shows that acetylation is primarily lost during the first 48 hr of differentiation, an effect that is inhibited by 10 mM acetate.
(C and D) Acetate also caused a significant increase in H3 and H4 acetylation, with no effect on H1.4 methylation.
(E–L) Immunofluorescence staining of H3K9/K27 acetylation (green) and H3K27me3 methylation (red) during early differentiation. (E and F) Acetate induces a
dose-dependent increase of K9/K27 histone acetylation in hESCs in SpDiff. Acetylation is pronounced at concentrations above 0.3mM. (G and H) Anacardic acid
(ANAC), a histone acetyl transferase (HAT) inhibitor, abolished acetate-induced histone acetylation in a dose-dependent manner. (I and J) Immunofluorescence
microscopy of I3 hESCs for K9/K27ac (green) and K27me3 (red) showed DCA (5 mM) significantly increased, while 2-DG (1.25 mM) significantly decreased
histone acetylation after 24 hr. (K and L) BrPA (10 mM) significantly decreased histone acetylation after 24 hr. The addition of 10 mM acetate reversed this effect.
Error bars represent standard errors. *p% 0.05; **p% 0.01; ***p% 0.001.of acetate to cell medium blocked histone deacetylation above
a concentration of 300 mM (Figures 4E and 4F). High doses
of acetate induced hyper-acetylation (p < 0.001). Addition of
anacardic acid (ANAC), a histone acetyltransferase inhibitor,
abolished the acetylation of H3K9/K27 by acetate (Figures 4G
and 4H).
Next, we sought to link the change in histone acetylation to
the shift in glycolysis we identified in early differentiation.
Indeed, inhibition of glycolysis by 2-DG or BrPA decreased
H3K9/K27 acetylation in undifferentiated hESCs (p < 0.05 and
p < 0.001, respectively) (Figures 4I–4L). This deacetylationCewas completely reversed by the addition of acetate (p <
0.001) (Figure 4L). Moreover, the addition of DCA, a PDK inhib-
itor that redirects pyruvate toward Ac-CoA, increased histone
acetylation (p < 0.05) (Figures 4I and 4J). These results demon-
strate that glycolytic production of Ac-CoA drives histone acet-
ylation in pluripotent stem cells.
Metabolic Regulation of Ac-CoA Modulates ESC
Pluripotency
TheWarburg effect is thought to drive glucose toward lactate for
the rapid production of ATP and nucleotides. The identification ofll Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc. 397
Figure 5. Glycolysis Regulates Stem Cell Pluripotency
(A–K) FACS analyses of H1 hESCs expressing OCT4-GFP and stained with Tra-1-81. Left vertical axis and red bars represent the percentage of cells, which are
positive for both pluripotency markers. Right vertical axis and blue bars represent the percentage of cells, which are negative for both pluripotency markers.
(A and B) Inhibition of glycolysis by 1.25 mM 2-DG or 10 mMBrPA significantly decreased the percentage of cells expressing both pluripotent markers, increasing
the percentage of non-expressing cells. (C) H1 OCT4-GFP cell numbers are compared for treated versus non-treated cells. No significant effect of glycolytic
inhibitors was noted on cell proliferation. (D and E) Four-day treatment of H1 hESCs with BrPA (5 or 10 mM) caused a dose-dependent loss in pluripotency
markers. Acetate stimulation inhibited the downregulation of both markers. (F and G) Pyruvate dehydrogenase kinase (PDK) inhibitor DCA (5 mM) increased the
percentage of cells positive for OCT4 and Tra-1-81 after 4 days of stimulation. (H and I) Inhibition of cholesterol synthesis in H1 hESCs by 10 mM lovastatin
(‘‘statin’’) similarly increased the percentage of cells positive for both pluripotency markers compared to the DMSO control. (J and K) BMS303141, an ACLY
inhibitor, significantly decreased the percentage of both OCT4- and Tra-1-81-positive cells. Acetate added to cell media reversed this effect. Error bars represent
standard deviation. *p% 0.05; **p% 0.01; ***p% 0.001.a glycolytic induction of histone acetylation in pluripotent cells
suggests that Ac-CoA production may be an essential factor in
maintaining pluripotency. To examine the effect of Ac-CoA on
pluripotency, we first blocked glycolysis in pluripotent cells up-
stream of pyruvate using 2-DG and BrPA. Four-day treatment
with either inhibitor caused a significant loss in pluripotency
markers OCT4 and Tra-1-81 (p < 0.05) (Figures 5A and 5B)
without affecting cell proliferation (Figure 5C). This inhibition
was reversed by the addition of acetate (p < 0.05) (Figures 5D
and 5E). To further examine this pathway, we used DCA, a pyru-
vate dehydrogenase kinase (PDK) inhibitor that redirects pyru-
vate toward Ac-CoA. DCA was recently shown by Folmes and
colleagues to block reprogramming to iPSCs (Folmes et al.,
2011). However, in our system DCA redirection of pyruvate to-
ward Ac-CoA significantly increased the percentage of pluripo-
tent cells expressing OCT4 and Tra-1-81 (p < 0.05) (Figures 5F
and 5G).398 Cell Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc.In addition to being a substrate for histone acetylation and
oxidative phosphorylation, Ac-CoA can also be used to synthe-
size cholesterol. Indeed, pluripotent cells synthesized choles-
terol when grown inmTeSR culturemedium (Figure 2D). To block
cholesterol synthesis from Ac-CoA, we used lovastatin, an
HMG-CoA reductase inhibitor, and observed an increase in
OCT4+ + Tra-1-81+ pluripotent cells (p < 0.05), similar to DCA
treatment (Figures 5H and 5I).
Finally, our gene expression and proteomic analyses point to a
5- and 2-fold decrease, upon pluripotent stem cell differentiation,
in ACLY, a major enzyme responsible for production of Ac-CoA
for histone acetylation (Figure 2H; Figure S2A) (Wellen et al.,
2009). To show ACLY involvement, we used BMS303141, a spe-
cific ACLY inhibitor. BMS303141 significantly decreased the
expression of pluripotency markers, and this effect was
completely reversed by the addition of acetate (Figures 5J and
5K). To exclude a possible apoptotic effect of the different
Figure 6. Metabolic Regulation of Histone
Acetylation in Pluripotent Cells and Early
Differentiation
(A) Glycolysis in pluripotent cells is increased, re-
sulting in increased levels of Ac-CoA and histone
acetylation.
(B) Upon early differentiation, Ac-CoA is con-
sumed in the TCA cycle, yielding less histone
acetylation.inhibitors used, a TUNEL assay was performed, with no effect
seen for any of the inhibitors used at the specified concentrations
for 4 days (Figures S2B and S2C). Modulation of fatty acid oxida-
tion did not affect pluripotency (Figures S3D and S3E).
Altogether, our results show that redirection of metabolic flux
away from Ac-CoA is a critical factor mediating the loss of
pluripotency.
DISCUSSION
Differentiation of pluripotent stem cells is a complex phenome-
non regulated on multiple levels. In this work we focused on
the earliest events that accompany the gradual loss of pluripo-
tent potential, a time point that is poorly understood (Dejosez
and Zwaka, 2012; Drukker et al., 2012).
To the best of our knowledge, the metabolites identified in the
current study construct the first metabolic profile of early-differ-
entiating cells as well as the first study of the metabolome of
PSCs in suspension. Our findings show that aerobic glycolysis
plays a critical role in maintaining histone acetylation, associated
with the open chromatin structure of PSCs. We show that this
glycolytic switch turns off during the first 24 hr of differentiation,
leading to Ac-CoA deprivation-mediated loss of histone acetyla-
tion and pluripotency markers. These findings mark the earliest
metabolic switch identified to date, linking the Warburg effect
with epigenetic regulation of pluripotent stem cells (Figure 6).
The Warburg effect, defined by the fermentation of glucose to
lactate (Metallo and Vander Heiden, 2013), was first described in
cancer cells by Nobel laureate Otto Heinrich Warburg in 1924
and more recently reported in embryonic and induced pluripo-
tent stem cells (Folmes et al., 2011; Panopoulos et al., 2012;
Zhu et al., 2010). Recent work comparing PSCs to terminally
differentiated cells showed low levels of oxidative phosphoryla-
tion in PSCs and increased aerobic glycolysis due to inactivation
of pyruvate dehydrogenase (PDH) (Varum et al., 2011) or the
expression of uncoupling protein 2 (UCP2) (Zhang et al., 2011).
In contrast, our results, tracking the first steps of differentiation,
show a similar loss of glycolysis, minor difference in UCP2
expression, and an actual increase in PDHB (Figures 2E–2H),
suggesting that a different mechanism might be responsible
for the lack of oxidative phosphorylation in pluripotent cells.
This increase in glycolysis is known to generate ATP at a faster
rate than oxidative phosphorylation, with lower ROS production,
important features for rapidly proliferating cells (Xu et al., 2013).
Glycolysis also shunts into the pentose phosphate pathway, pro-
ducing much-needed nucleotides for proliferation (Vander Hei-
den et al., 2009). However, these advantages do not explainCethe increased conversion of glucose to Ac-CoA, which we
observed using high-resolution NMRand 13C glucose tracing us-
ing mass spectrometry (Figures 1 and 2G; Figure S1). Aerobic
glycolysis is thought to direct pyruvate toward lactate rather
than Ac-CoA (Vander Heiden et al., 2009). In fact, inhibiting
PDK in cancer cells redirects pyruvate from lactate to Ac-CoA
and oxidative phosphorylation, effectively killing the cells (Pear-
son, 2007). Surprisingly, the same redirection from lactate to Ac-
CoA actually increases pluripotency in hESCs (Figure 5F) without
affecting their viability. These results suggest an underlying
metabolic difference between cancer cells and PSCs, but also
stand in contrast to the findings of Folmes and colleagues
(Folmes et al., 2011). Folmes and his co-workers showed that
acetate production increased during reprogramming of mouse
cells to iPSC. This observation may be explained by the change
in Ac-CoA levels, as Ac-CoA, the active entity, is in equilibrium
with acetate. As Ac-CoA is not normally secreted from cells, ac-
etatemay serve as a form of paracrine signaling designed to sup-
port the pluripotent state of next-door neighbors in the colony.
However, treatment with DCA blocked reprogramming to
iPSC. Together with the results shown here and previous studies
on cancer cell metabolism (Vander Heiden et al., 2009), these re-
sults may suggest that oxidative phosphorylation is inactive in
the pluripotent state, allowing the cells to push pyruvate to Ac-
CoA through overexpression of ACLY. However, cancer cells
and somatic cells undergoing reprogramming actively seek to
avoid a functional TCA cycle. In that case, DCA treatment reig-
nites oxidative phosphorylation, reducing reprogramming effi-
ciency or outright killing cancer cells.
Interestingly, despite the key role suggested for fatty acids in
mouse ESC differentiation (Yanes et al., 2010) and energy gener-
ation, our data suggest that lipidmetabolism plays aminor role in
early differentiation. We show that Ac-CoA utilization in choles-
terol biosynthesis negatively effects pluripotency. However, fatty
acid oxidation is minor, and its modulation using lipids and phar-
maceutical agents showed no effect on the expression of plurip-
otency markers (Figures S3D and S3E).
In summary, our work reveals a crucial role for glycolysis in the
maintenance of the pluripotent state. We show that human and
mouse ESCs direct pyruvate toward Ac-CoA and histone acety-
lation. Blocking Ac-CoA production causes loss of pluripotency,
while preventing its consumption through pharmaceutical or
metabolic modulation can significantly delay the differentiation
of the cells. The results elucidate an important link between
metabolism, pluripotency, and chromatin regulation and could
be applied to optimize the culture of PSCs or removing tera-
toma-inducing cells from differentiated cultures.ll Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc. 399
Table 1. Multiple Reaction Monitoring (MRM) Transitions and
Parameters for Ac-CoA and 13C2-Ac-CoA
Name
Q1 Q3 DP EP CXP CE
m/z m/z V V V eV
Ac-CoA 1 (quantifier transition) 808.1 78.9 50 10 7 126
Ac-CoA 2 (qualifier transition) 403.5 78.9 35 10 19 112
13C2-Ac-CoA 1
(quantifier transition)
810.1 78.9 50 10 7 126
13C2-Ac-CoA 2
(qualifier transition)
404.8 78.9 35 10 19 112
Calibration samples of Ac-CoA (0.1–2 mM) were prepared in water and
cell extracts according to the standard addition method. Q1, quadrupole
1;m/z, mass-to-charge ratio; Q3, quadrupole 3; DP, declustering poten-
tial; V, volts; EP, entrance potential; CXP, collision cell exit potential; CE,
collision energy; eV, electronvolts.EXPERIMENTAL PROCEDURES
hESC Culture
hESC lines I3 and I4 were maintained as previously described (Amit et al.,
2011). WA01 (H1) and H1 OCT4-eGFP were purchased from the WiCell
Research Institute. Cells were maintained in StemCell Technologies mTeSR1
culture medium onMatrigel-coated plates and passaged every 4–7 days using
dispase II (Roche).
mESC Culture
R1 OCT4-GFP line was a kind gift of Prof. Andras Nagy of the Lunenfeld
Research Institute. Briefly, mESCs were maintained in DMEM supplemented
with 15% FBS, sodium pyruvate, L-glutamine, b-mercaptoethanol, and
1,000 U/ml murine leukemia inhibitory factor (LIF). Cells were passaged every
2–3 days using trypsin EDTA.
High-Density Suspension Cultures
To produce a large number of cells for metabolic studies, I3 and I4 hESC lines
were cultured in high-density suspension as previously described (Amit et al.,
2011). Briefly, hESCs were removed from culture dishes using collagenase IV,
broken into clumps using a pipette, and transferred to a low-adhesion 60 mm
dish at a density of 3 3 106 cells/ml. After three passages of adaptation to
suspension, cells were transferred to 100 ml spinner flasks stirred at 75 rpm.
Cultures were maintained in suspension medium (SM10F) culture medium
composed of DMEM/F12 supplemented with 15% KO serum, L-glutamine,
b-mercaptoethanol, 10 ng/ml bFGF, and 100 pg/ml of IL6RIL6 chimera. Spon-
taneous differentiation was carried out in suspension by removing bFGF and
IL6RIL6 chimera from the culture medium, minimizing culture and medium
artifacts.
Sample Preparation for NMR Analysis
I3 and I4 hESCs were collected from spinners, spun down, and washed with
PBS. Samples of 5 3 106 cells were snap-frozen in liquid nitrogen and stored
at 80C for subsequent analysis. Samples were thawed and quenched in
60% MeOH, ultrasonicated at 4C, and lyophilized. Lyophilized samples
were resuspended in ice-cold methanol/chloroform (2:1), homogenized for
5 min, and finally mixed with a volume of chloroform/water (1:1). Phase sepa-
ration was carried out by 20 min centrifugation at 1,500 g at 4C. Top aqueous
and bottom organic layers were transferred to clean tubes. Middle protein ring
was re-extracted by repeating the process and samples were pooled. Tubes
were finally dried in SpeedVac and stored at 80C until analysis. Medium
samples were collected from culture density of 1 3 106 cells/ml, centrifuged
to remove cells and debris, and stored at80C until analysis. Sample volume
was adjusted according to protein concentration.
NMR Analysis
High-resolution NMR analysis was carried out at the CNRS (Lyon, France). 1H-
NMR spectra were recorded on a Bruker Avance III spectrometer operated at400 Cell Metabolism 21, 392–402, March 3, 2015 ª2015 Elsevier Inc.800.15 MHz (1H resonance frequency; 18.8 T), equipped with a 5 mm TXI pro-
behead and refrigerated high-throughput sample changer. The temperature
was regulated at 300 K throughout the experiments. Frozen samples were re-
constituted in D2O phosphate buffer solution (pH 7.2) containing 0.1 mM and
1 mM TSP (3-(trimethylsilyl)propionate-2,2,3,3-d4) for cell extracts and media
samples, respectively. For each sample, 1H 1D NOESY and CPMG experi-
ments (media), or 1H 1D NOESY alone (cell extracts) were acquired with pre-
saturation of the water signal. All free induction decays (FIDs) were multiplied
by an exponential function corresponding to a 0.3 Hz line-broadening factor
prior to Fourier transform. Phase and baseline of the spectra were manually
adjusted in TopSpin 3.1 (Bruker Biospin GmbH). Spectra were calibrated on
the a-glucose doublet at d = 5.23 ppm or the TSP signal at d = 0.016 ppm
for the cell aqueous extracts or the media samples respectively, and reduced
over the chemical shift range 0.1–10 ppm to 9,900 bins (103 ppm wide) with
integration of signal intensity using the AMIX software (Bruker GmbH). Resid-
ual water signal (d = 4.65–4.9 ppm) was discarded prior to further analysis.
Untargeted Metabolomics Data Analysis
NMR spectral bins were analyzed using MetaboAnalyst 2.0 (Xia et al., 2009).
Data were filtered by interquantile range and normalized to the sum. Following
PCA and random forest outlier detection, two samples were excluded from the
I4 media dataset. PLS regression was performed using the PLSR function.
Classification and cross-validation were performed using the corresponding
wrapper function offered by the caret package. In order to assess if the class
discrimination is statistically significant, a permutation test was performed. In
each permutation, a PLS-DA model was built between the data (X) and the
class labels (Y) using the optimal number of components, determined by cross
validation for themodel based on the original class assignment. The ratio of the
between sum of the squares and the within sum of squares for the class
assignment prediction of each model was calculated. Hierarchical clustering
was performed using Spearman correlation and theWard clustering algorithm.
Metabolite identification was performed using Chenomx NMR suite 7.7 (Che-
nomx Inc.).
Mass Spectrometry for 13C-Ac-CoA
I3 hESCsweremaintained for 48 hr in SpDiff or mTeSRmedia. Following 8 hr of
incubation with D-glucose-13C6, cells were scraped in cold 80% MeOH, snap
frozen in liquid nitrogen, and transferred to 80C until analysis. Cell pellets
were thawed on ice and ultrasonicated at 4C. Samples were then centrifuged
at 4C, and supernatant was transferred to clean tubes. Pellets were left for
protein quantification. Samples were dried in SpeedVac and reconstituted in
HPLC-grade water. The chromatography was performed using a Shimadzu
UHPLC System, series Nexera. The chromatographic separations were per-
formed on a Kinetex (Phenomenex) column (C18, 2.6 mm particle size, 100 A˚
pore size, 503 2.1 mm). The injection volume was 20 ml, the oven temperature
was maintained at 40C, and the autosampler tray temperature was main-
tained at 15C. Chromatographic separation was achieved using a linear
gradient program at a constant flow rate of 0.35 ml/min over a total run time
of 6min from 99% to 60% solvent A. Solvent A was 20mMammonium acetate
and 20 mM ammonium hydroxide (pH 9) in water and solvent B was 20 mM
ammonium acetate in methanol. Water was used for washing the needle prior
to each injection cycle. All samples were analyzed in duplicate. Ac-CoA was
detected by an AB Sciex Triple Quad 5500 mass spectrometer in negative
ion mode using electrospray ionization (ESI) and multiple-reaction monitoring
(MRM) mode of acquisition. The ions [Ac-CoA-H] (m/z 808.1) and [Ac-CoA-
2H]2 (m/z 403.5) were selected in the first mass analyzer and fragmented in
the collision cell followed by detection of the products of fragmentation in
the second mass analyzer. Two transitions were monitored: m/z 808.1 /
78.9 (quantifier) and m/z 403.5/ 78.9 (qualifier). The TurboIonspray probe
temperature was set at 650C with the ionization potential at 4,500 V. Data
acquisition and analysis were performed on a Dell OptiPlex 960 computer
with Analyst 1.6 software distributed by AB Sciex (Table 1).
Proteome Analysis
Proteome analysis was performed as described by us previously (Liu et al.,
2012). Briefly: to achieve quantitative proteome data, a ‘‘heavy’’ proteome
reference was spiked in equal amounts in every sample. Harvested cells
were lysed in an appropriate amount of urea buffer (8M urea, 50 mM Tris-HCl
[pH 7.4]). The lysateswere cleared by centrifugation at 14,000 rpm for 15min at
4C. Disulfide bridges were then reduced in DTT 2 mM for 30 min at 25C, and
successively free cysteines were alkylated in 11 mM iodoacetamide for 20 min
at room temperature in the darkness. LysC digestion was performed by adding
LysC (Wako) in a ratio of 1:40 (w/w) to the sample and incubating it for 18 hr
under gentle shaking at 30C. After LysC digestion, the samples were diluted
three times with 50 mM ammonium bicarbonate solution, immobilized trypsin
(Applied Biosystems) was added, and samples were incubated for 4 hr under
rotation at 30C. Digestion was stopped by acidification with trifluoroacetic
acid and removal of trypsin beads by centrifugation. After digestion, peptides
were extracted and desalted before analysis by mass spectrometry. Five mi-
croliters were injected in duplicate on a LC-MS/MS system (Agilent 1200 [Agi-
lent Technologies] and LTQ-Orbitrap Velos [Thermo]), using a 240min gradient
from 5% to 40%of solvent B (80%acetonitrile, 0.1% formic acid; solvent A 5%
acetonitrile, 0.1% formic acid). For the chromatographic separation, a 20 cm
capillary (75 mm inner diameter) was packed with 3 mm C18 beads (ReproSil-
Pur C18 AQ, Dr. Maisch). On one end of the capillary, a nanospray tip was
generated using a laser puller (P-2000 Laser Based Micropipette Puller, Sutter
Instruments), allowing fretless packing. Then a nanospray source was oper-
ated with a spray voltage of 1.9 kV and an ion transfer tube temperature of
260C. Data were acquired in data-dependent mode, with one survey MS
scan in the Orbitrap mass analyzer followed by up to 20 MS/MS scans in the
ion trap on the most intense ions (intensity threshold, 500 counts). Once
selected for fragmentation, ions were excluded from further selection for
30 s to increase new sequencing vents. Proteome raw data were analyzed us-
ing the MaxQuant proteomics pipeline (v.1.1.1.36) and the built-in Andromeda
search engine with the International Protein Index Mouse database. Carbami-
domethylation of cysteines was chosen as fixed modification, and oxidation of
methionine and acetylation of N terminus were chosen as variable modifica-
tions. The search engine peptide assignments were filtered at 1% FDR and
the feature match between runs was not enabled; second peptide feature
was enabled, while other parameters were left as default. Two ratio counts
were set as threshold for quantification. Gene Ontology analysis was per-
formed using a DAVID tool.
Early Endoderm Induction
Cells were cultured for 48 hr in RPMI medium supplemented with B27,
100 ng/ml activin A, and 50 ng/ml Wnt3A. Media were changed after 24 hr,
and the cells were fixed for analysis.
Flow Cytometry
Flow cytometry was carried out on Becton Dickinson FACSAria III. Cells were
washed in PBS, dissociated using TrypLE select (Invitrogen), and centrifuged
at 300 g for 5 min. Cell pellets were resuspended in PBS containing 1% FBS,
filtered through a cell strainer to remove aggregates, and incubated with pri-
mary conjugated antibodies for 1 hr on ice. Cells were then washed twice, sus-
pended in PBS with 1% FBS, and analyzed. Live, single cells were gated by
GFP, PE, or side-scatter emission. Unlabeled cells and isotype controls
were used to set gates for negative populations. Data analysis was performed
using TreeStar Inc. FlowJo software.
Immunofluorescence Microscopy
Cultures were washed twicewith PBS and fixedwith 4%paraformaldehyde for
15 min at room temperature. Cells were permeabilized with 0.5% Triton X-100
for 5 min and blocked with 1% BSA for 1 hr. Cells were incubated with primary
antibodies for 1 hr, then washed and incubated with secondary antibodies for
1 hr at room temperature. Samples were imaged on a Zeiss LSM 700 micro-
scope. Images were analyzed using the ZEN 2011 software, as well as the
Broad Institute Cell Profiler image analysis software.
Antibodies
Primary PE-conjugated antibodies used for FACS analyses included anti-Tra-
1-60 and Tra-1-81 (1:20; eBioscience) as well as anti-SSEA4 (1:50; R&D Sys-
tems). Anti-H3K9/K27ac was a kind gift of Prof. H. Kimura of Osaka University.
Additional antibodies used include anti-H3K27me3 (1:1,000; EMD Millipore),
anti-H3ac (1:200; EMD Millipore), anti-H4ac (1:100; EMD Millipore), anti-H1.4
(1:200; EMDMillipore), and anti-SOX17 (1:100; R&D Systems). Secondary an-
tibodies were purchased from Jackson Immunoresearch Laboratories.CeQuantitative Gene Expression Analysis
Total cellular RNA was extracted using Life Technologies TRIzol reagent and
reversed transcribed using Promega ImProm-II kit according to manufacturer
directions. Real-time PCR was performed using Applied Biosystem Power
SYBR Green PCR Master Mix and analyzed on the company’s 7300 real-
time PCR system (Table S1).
TUNEL Assay
Quantitation of apoptotic cells was performed utilizing DeadEnd Fluorometric
TUNEL System (Promega) according to manufacturer directions. Briefly, cells
were permeabilized and exposed to fluorescein-12-dUTP and terminal deox-
ynucleotidyl transferase (TdT), dying apoptotic nuclei green. The reaction was
subsequently stopped and the cells counterstained for DAPI. A percent
apoptotic nucleus was calculated by dividing the number of TUNEL- to
DAPI-positive nuclei.
Drugs and Reagents
Drugs and reagents were purchased from Sigma-Aldrich unless otherwise
indicated. 2-DG, BrPA, and DCA were purchased from Santa Cruz Biotech-
nology. Lovastatin was purchased from Cayman Chemical. BMS 303141
was purchased from Tocris Bioscience. Ac-CoA standard was used from a
Biovision kit (see Metabolic Kits, below).
Metabolic Kits
Glucose and lactate levels were determined using commercial kits based on
glucose oxidase (Stanbio Laboratory) and lactate oxidase (Trinity Biotech
Bray), respectively. Ac-CoA, free fatty acids, and cholesterol were quanti-
fied by CoA derivatives and cholesterol oxidase, respectively, using com-
mercial kits purchased from BioVision. Ketone bodies were determined by
NADH disappearance using a commercial kit purchased from Abnova. All
targeted metabolic assays were performed according to manufacturer’s
instructions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.cmet.2015.02.002.
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